Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024